Realizing the value of plant natural products: from metabolic engineering to biorefining - 16th Nov 2012

Friday, 16 November 2012

The Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage, Herts, SG1 2FX

Plants produce a wide range of natural products with valuable activities as pharmaceuticals, nurtaceuticals, crop protection agents, food ingredients and personal care products. With a growing public interest in ‘naturals’ and policy drivers to increase sustainability of chemical production, there is now a major opportunity for biotechnologists to increase the supply and diversity of phytochemicals available for industrial applications. In this meeting these opportunities will be reviewed, along with the approaches being employed nationally to meet this demand using a combination of plant breeding, metabolic engineering and biorefining.

This event has CPD accreditation and will have a discussion panel session.

On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event

Meeting Chair: Professor Robert Edwards , Chief Scientist, The Food and Environment Research Agency

 

 

9:00 – 9:45 Registration

 

9:45 – 10:00 Introduction by the Chair: Professor Robert Edwards , Chief Scientist, The Food and Environment Research Agency

 

10:00 – 10:30 TBC

Professor John Ward, University College London, United Kingdom

 

10:30 – 11:00 Cultured cambial meristematic cells as a source of plant natural products

Professor Gary Loake, The University of Edinburgh, Scotland

A plethora of important, chemically diverse natural products are derived from plants. In principle, plant cell culture offers an attractive option for producing many of these compounds. However, it is often not commercially viable because of difficulties associated with culturing dedifferentiated plant cells (DDCs) on an industrial scale. To bypass the dedifferentiation step, we isolated and cultured innately undifferentiated cambial meristematic cells (CMCs). Using a combination of deep sequencing technologies, we identified marker genes and transcriptional programs consistent with a stem cell identity. This notion was further supported by the morphology of CMCs, their hypersensitivity to γ-irradiation and radiomimetic drugs and their ability to differentiate at high frequency. Suspension culture of CMCs derived from Taxus cuspidata, the source of the key anticancer drug, paclitaxel (Taxol), circumvented obstacles routinely associated with the commercial growth of DDCs. These cells may provide a cost-effective and environmentally friendly platform for sustainable production of a variety of important plant natural products.

 

 

11:00 – 11:30 Speakers’ photo then mid-morning break and trade show

Please try to visit all the exhibition stands during your day at this event. Not only do our sponsors enable Euroscicon to keep the registration fees competitive, but they are also here specifically to talk to you

 

 

11:30 – 12:00 Engineering flavonoid metabolism in yeast
Professor Robert Edwards , Chief Scientist, The Food and Environment Research Agency
Phenylpropanoids are simple aromatic natural products found in all plants which are used as the building blocks for a wide range of polyphenols including a diverse array of flavonoids with activities as diverse as dietary cytoprotectants, colourants and flavour enhancers. Using polyprotein technology we have engineered bakers’ yeast to transform readily available phenylpropanoids left over from brewing and biofuel production into high value flavonoids, including glycosylated derivatives with uses as artificial sweeteners. The approach adopted shows the value of effectively transferring plant metabolic pathways into non-natural hosts to extend the diversity of end products which can be generated in useful quantities.

 

12:00 – 12;30 Metabolic engineering of high value lipids in transgenic plants
Professor Johnathan Napier, Rothamsted Research Limited, Hertfordshire, United Kingdom
Using genetic engineering it is now possible to generate transgenic plants which have the capacity to synthesise high value fatty acids such as the omega-3 long chain polyunsaturates.

 

12:30 – 13:30 Lunch and trade show

This is also a good time to fill out your feedback forms

 

 

13:30– 14:30 Question and Answer Session

Delegates will be asked to submit questions to a panel of experts. Questions can be submitted before the event or on the day

 

14:30 – 15:00 Afternoon Tea/Coffee and trade show

15:00 – 15:30 A ten gene cluster responsible for synthesis of the anticancer alkaloid noscapine in opium poppy

Professor Ian Graham, CNAP Director and Weston Chair of Biochemical Genetics, University of York, United Kingdom

Noscapine is an antitumor alkaloid from opium poppy that binds tubulin, arrests metaphase and induces apoptosis in dividing human cells. We recently discovered a cluster of 10 genes encoding five distinct enzyme classes that are responsible for noscapine production in poppy (Winzer et al., Science, 2012). Virus induced gene silencing resulted in accumulation of pathway intermediates allowing a novel biosynthetic pathway to be proposed. This advance adds to our knowledge of gene clusters in plants and will enable improvement in commercial production of noscapine and related bioactive molecules.

 

15:30 - 16:00 Genome mining and metabolic engineering for triterpene synthesis
Professor
Anne Osbourn, Associate Research Director, John Innes Centre
Plants produce a huge array of natural products, many of which are specialised metabolites associated with particular species. These secondary metabolites often have important ecological functions. Although the ability of plants to perform in vivo combinatorial chemistry by mixing, matching and evolving the genes required for different secondary metabolite biosynthetic pathways is likely to have been critical for survival and diversification of the Plant Kingdom we know very little about the mechanisms underpinning this process. This talk will focus on plant natural product function and synthesis, the origins of metabolic diversity and potential for metabolic engineering, drawing on our research on triterpene synthesis in crop and model plants. Triterpenes have important ecological and agronomic functions, contributing to pest and pathogen resistance and to food quality in crop plants. They also have a wide range of commercial applications in the food, cosmetics and pharmaceutical sectors.

16:00 – 16:30 Chairman’s summing up

 

 


About the chair
Robert Edwards is the Chief Scientist at the Food and Environment Research Agency (Fera) and also runs a research group at the University of York in the Centre for Novel Agricultural Products, where he has a Chair in Crop Protection. He was formerly Head of Biology at Durham University, with 26 years of postdoctoral experience as a Plant Biochemist working in the public and private sectors in the UK and USA. As co-ordinator of the cross Research Council-funded network ‘Synthetic Plant Products for Industry’ he has been working with industrialists and academics on applications for synthetic biology in the improvement and utilisation of crop plants in biorefining. Research interests in metabolic engineering include manipulating high value flavonoid production and the biotransformation of synthetic chemicals. Expertise in natural products at Fera includes state-of-the-art facilities in measuring a wide range of analytes in food and environmental samples and research programmes in biorenewables.

About the Speakers
Johnathan A. Napier’s research on the biosynthesis of polyunsaturated fatty acids has delivered some of the key advances in the last 15 years. He obtained his BSc from the University of Nottingham, followed by a PhD in plant biochemistry from King’s College, London. He carried out post-doctoral research in the Department of Plant Sciences, University of Cambridge, then taking up a position at Long Ashton Research Station in Bristol. His research group relocated to Rothamsted Research in 2003 where he is currently Institute Assistant Director and Programme Leader. Johnathan is also an Affiliated Lecturer at the University of Cambridge.

Gary Loake’s research aims to understand the molecular mechanisms underpinning plant disease and resistance.
1996 Joined University of Edinburgh, 1995-1996 Senior Postdoctoral Fellow, The Plant Laboratory, University of York, UK, 1991-1994 Salk-Noble Plant Biology Fellow, Salk Institute, California, USA, 1990-1991 Salk-Noble Plant Biology Fellow, Samuel Robert Noble Foundation, 1990 Ph.D. University of Durham, Durham, UK

Anne Osbourn is Associate Research Director of the John Innes Centre, Norwich. Her research focuses on plant natural products - function, synthesis and metabolic diversification. She is an author of over 100 peer-reviewed scientific publications and recently co-edited a comprehensive textbook on plant-derived natural products [Lanzotti V & Osbourn A. (2009) Plant-derived natural products – Synthesis, function and application. Springer, New York, USA]. She has also developed and co-ordinates the Science, Art and Writing (SAW) initiative, a cross-curricular science education programme for schools (www.sawtrust.org).

 

Ian Graham holds the Weston Chair of Biochemical Genetics and is the Director of the Centre for Novel Agricultural Products (CNAP) at the University of York. His research interests focus on seed biology and metabolic engineering of novel oils and other high value chemicals. Current projects range from the development of novel oilcrops such as Jatropha curcas to medicinal plants such as Artemisia annua that produces the anti-malarial compound artemisinin and opium poppy that produces analgesics and other compounds for the pharmaceutical industry. Funding for Ian’s research comes from a range of sources including industry, UK Government, EU and various charities.

Keywords: High value products; metabolic engineering; non-food crops; biorefining; natural products, monoclonal antibodies, hybridoma, recombinant protein, monoclonal antibody, production, hollow fiber., hollow fiber, double membrane, cell culture; viral vaccine; gene therapy; stem cell; scale-up, Biorefining, Design of Experiments, process scale-up, industrial biotechnology, biorenewable chemicals, enzymes, Phenylpropanoids, cytoprotectants, flavonoid, yeast, Transgenic plants, omega-3 polyunsaturates, metabolic engineering, Metabolic engineering; terpenes; synthetic biology; plant protection; anti-cancer drugs, Alkaloids, Papaver somniferum, gene cluster, biochemical pathway

Registration Web Site: http://www.regonline.co.uk/smallscale12

 

 

Dont forget to sign up to Euroscicons’ e-newsletter at www.euroscicon.com/signup.htm to keep up to date with European Life Science news and events and to be notified of the follow up to this event

This meeting was organised by Euroscicon (www.euroscicon.com), a team of dedicated professionals working for the continuous improvement of technical knowledge transfer to all scientists. Euroscicon believe that they can make a positive difference to the quality of science by providing cutting edge information on new technological advancements to the scientific community. This is provided via our exceptional services to individual scientists, research institutions and industry.

 


Post expires at 8:25am on Friday November 16th, 2012


Tags: , , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Sign up for our Newsletter

testimonials

RSS Euroscicon News

This site is regularly updated with information regarding the one day Life Science events within the UK run by Euroscicon

Euroscicon